Publications in collaboration with researchers from Dana–Farber Cancer Institute (1)

2026

  1. IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma

    Blood, Vol. 147, Núm. 26, pp. 3195-3208